LE MOLI, ROSARIO

LE MOLI, ROSARIO  

Dipartimento di Medicina e Chirurgia  

Mostra records
Risultati 1 - 20 di 47 (tempo di esecuzione: 0.007 secondi).
Titolo Data di pubblicazione Autore(i) File
A Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma: Clinical and Pathologic Features and Outcomes of 34 Consecutive Cases 1-gen-2011 Regalbuto, Concetto; Malandrino, Pasqualino; Tumminia, Andrea; Le Moli, Rosario; Vigneri, Riccardo; Pezzino, Vincenzo
A novel methodology for epidemic risk assessment of COVID-19 outbreak 1-gen-2021 Pluchino, A.; Biondo, A. E.; Giuffrida, N.; Inturri, G.; Latora, V.; Le Moli, R.; Rapisarda, A.; Russo, G.; Zappalà, C.
A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy 1-gen-1998 Lunetta, M.; Le Moli, R.; Grasso, G.; Sangiorgio, L.
Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution 1-gen-2016 Castoro, C.; Le Moli, R.; Arpi, M. L.; Tavarelli, M.; Sapuppo, G.; Frittitta, L.; Squatrito, S.; Pellegriti, G.
Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism 1-gen-2020 Le Moli, Rosario; Malandrino, Pasqualino; Russo, Marco; Lo Giudice, Fabrizio; Frasca, Francesco; Belfiore, Antonino; Vigneri, Riccardo
Determinants of clinical outcome in patients with moderate/severe Graves' orbitopathy undergoing treatment with parenteral glucocorticoids: a retrospective study 1-gen-2024 Le Moli, Rosario; Naselli, Adriano; Costanzo, Gabriele; Piticchio, Tommaso; Tumino, Dario; Pellegriti, Gabriella; Frasca, Francesco; Belfiore, Antonino
Determinants of Liver Damage Associated with Intravenous Methylprednisolone Pulse Therapy in Graves' Ophthalmopathy 1-gen-2007 Le Moli, Rosario; Baldeschi, Lelio; Saeed, Peerooz; Regensburg, Noortje; Mourits, Maarten P.; Wiersinga, Wilmar M.
Determinants of longterm outcome of radioiodine therapy of sporadic non- toxic goitre 1-gen-1999 Le Moli, R.; Wesche, M. F. T.; Tiel-Van Buul, M. M. C.; Wiersinga, W. M.
Diabetic neuropathy: Prevalence, concordance between clinical and electrophysiological testing and impact of risk factors 1-gen-1997 Sangiorgio, L.; Iemmolo, R.; Le Moli, R.; Grasso, G.; Lunetta, M.
Different effects of octreotide by continuous night infusion at increasing rate or by evening injections at different times on morning hyperglycemia and growth hormone levels in insulin-dependent diabetic patients 1-gen-1998 Lunetta, M.; Di Mauro, M.; Le Moli, R.
Early detection of suspicious lymph nodes in differentiated thyroid cancer 1-gen-2022 Frasca, Francesco; Piticchio, Tommaso; Le Moli, Rosario; Tumino, Dario; Cannavò, Salvatore; Ruggeri, Rosaria Maddalena; Campennì, Alfredo; Giovanella, Luca
Early Massive Fibrosis of a Single Extraocular Muscle Causing Severe Unilateral Euthyroid Graves’ Ophthalmopathy in a Patient with Hypercholesterolemia Who Smokes 1-gen-2023 Frazzetto, Giuseppe; Arpi, Maria Luisa; Regalbuto, Concetto; Belfiore, Antonino; Frasca, Francesco; Le Moli, Rosario
Effect of octreotide on blood glucose and counterregulatory hormones in insulin-dependent diabetic patients: The role of dose and route of administration 1-gen-1996 Lunetta, M.; Di Mauro, M.; Le Moli, R.; Nicoletti, F.
Effect of octreotide on blood glucose levels in poorly compensated insulin-dependent diabetics on insulin treatment|Effetti dell'octreotide sui livelli glicemici in diabetici insulino-dipendenti mal compensati con trattamento insulinico 1-gen-1992 Lunetta, M.; Di Mauro, M.; Le Moli, R.
Effect of octreotide on growth hormone, IGF-I, IGFBP-3, glucagon, cortisol and epinephrine response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients 1-gen-1997 Lunetta, M; Di Mauro, M; Le Moli, R; Nicoletti, F
Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function 1-gen-2001 Di Mauro, Maurizio; Papalia, G; Le Moli, R; Nativo, B; Nicoletti, F; Lunetta, M
Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients 1-gen-1997 Lunetta, M; Di Mauro, M; Le Moli, R; Nicoletti, F
Efficacy of Botulinum Toxin A for Treating Cramps in Diabetic Neuropathy 1-gen-2018 Restivo, D. A.; Casabona, A.; Frittitta, L.; Belfiore, A.; Le Moli, R.; Gullo, D.; Vigneri, R.
Establishment of reference values for endocrine tests II: Hyperprolactinemia 1-gen-1999 Le Moli, R
Evaluation of endocrine tests. A: The TRH test in patients with hyperprolactinaemia 1-gen-2003 Le Moli, R.; Endert, E.; Fliers, E.; Prummel, M. F.; Wiersinga, W. M.